Hepatic carboxylesterases are differentially regulated in PPARα-null mice treated with perfluorooctanoic acid

Xia Wen1, Angela A Baker1, Curtis D Klaassen2

  • 1Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, Piscataway, NJ, 08854, USA.

Toxicology
|January 28, 2019
PubMed

Insights

The environmental contaminant perfluorooctanoic acid (PFOA) alters liver enzyme expression and activity, impacting drug metabolism. This modulation occurs partly through the PPARα receptor, affecting how the body processes chemicals.

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Hepatic carboxylesterases (Ces) are crucial for metabolizing xenobiotics and endogenous lipids.
  • Nuclear receptors, including PPARα, regulate Ces expression and activity.
  • Perfluorooctanoic acid (PFOA), a widespread environmental contaminant, is linked to dyslipidemia and can activate PPARα.

Purpose of the Study:

  • To investigate the effect of PFOA on hepatic Ces expression and activity.
  • To determine the role of the PPARα receptor in PFOA-mediated modulation of Ces.

Main Methods:

  • Administration of PFOA to male C57BL/6 NCrl mice (wild-type and PPARα-null).
  • Assessment of Ces mRNA, protein, and activity in liver tissues.
  • Confirmation of PPARα activation via Cyp4a14 mRNA levels.

Main Results:

  • PFOA significantly increased Ces1 and Ces2 protein and activity in wild-type mice.
  • PFOA modulated the expression of various Ces1 and Ces2 mRNA subtypes in a PPARα-dependent manner.
  • In PPARα-null mice, PFOA still induced certain Ces subtypes, suggesting involvement of other nuclear receptors like CAR and PXR.

Conclusions:

  • PFOA alters hepatic Ces expression and activity, contributing to its toxicological effects.
  • PPARα is a key mediator of PFOA's effects on Ces, but other pathways also contribute.
  • Understanding these mechanisms is vital for assessing PFOA's health risks.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Respiratory Regulation of Acid-Base Balance01:18

Respiratory Regulation of Acid-Base Balance

Respiratory compensation is a vital physiological process that stabilizes blood plasma pH by regulating the partial pressure of carbon dioxide (PCO2), a key determinant of pH levels. Most carbon dioxide in the blood dissolves and converts into carbonic acid (H2CO3). It dissociates into hydrogen ions (H+) and bicarbonate ions (HCO3⁻). There is also an inverse relationship between PCO2​​ and pH.
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
1.7K
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
1.7K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.7K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.8K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
274